Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden
스웨덴 스톡홀름에서 SARS-CoV-2 전염 첫 해 동안 헌혈자와 임산부의 혈청 양성
Original Article
[키워드] affecting
age
All participants
Antibody testing
approach
approaches
B‐cell
baseline
Bayesian framework
blood donor
Blood donors
carried
clinical trial
clinical trials
Cohort
community transmission
comparable
competent
complement
Control
COVID‐19
dissemination
FIVE
glycoprotein
healthy blood donor
healthy blood donors
healthy donor
IgG response
IgG responses
independent
individual
Infection
infections
information
intervals
Karolinska University Hospital
likelihood
lockdown
Metadata
mild infection
mRNA vaccination
Neutralizing antibody response
neutralizing antibody responses
pandemic
participant
Participants
population immunity
pregnant women
Prospective Study
random
Randomly
RBD
reached
receptor‐binding domain
recommendations
registration number
Result
review
sampling
SARS‐CoV‐2
SARS‐CoV‐2 infection
SARS‐CoV‐2 spike
SARS‐CoV‐2
screened
second wave
selected
sera
serology
seropositive
Seropositivity
Seroprevalence
setting
study period
Sweden
Swedish
Swedish Ethical Review Authority
symptomatic
tested
These data
titre
titres
trajectory
Transmission
trimer
vaccination
Vaccinations
was used
[DOI] 10.1111/joim.13304 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1111/joim.13304 PMC 바로가기 [Article Type] Original Article